GHIC Makes Anchor Investment in the Launch of the Women’s and Children’s Health Technology Fund
December 10, 2021
TORONTO, CA – Cross-Border Impact Ventures (CBIV) today announced the launch of its Women’s and Children’s Health Technology Fund, which will invest in health technology companies that address the health needs of women, children, and adolescents or make health systems more resilient. GHIC is providing an anchor investment as a Limited Partner in the Fund with the financial support of the German government through its KfW Development Bank.
CBIV has secured US$30 million in commitments towards a targeted fund size of more than US$100 million to invest in health technology companies with global growth, high return, and impact potential. Its primary focus is on medical device, diagnostic, and digital health companies based in North America, Europe, and Israel. Its secondary focus is on commercial stage companies in emerging markets with global technology transfer potential.
CBIV has set impact targets across its portfolio companies of 500,000 lives saved and improvements in the lives of 10 million underserved women and children in emerging markets.
Learn more in CBIV’s press release or at crossborder.ventures.